1. Home
  2. COCP vs JTAI Comparison

COCP vs JTAI Comparison

Compare COCP & JTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cocrystal Pharma Inc.

COCP

Cocrystal Pharma Inc.

HOLD

Current Price

$1.00

Market Cap

13.7M

Sector

Health Care

ML Signal

HOLD

JTAI

Jet.AI Inc.

HOLD

Current Price

$7.06

Market Cap

11.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
COCP
JTAI
Founded
2006
2018
Country
United States
United States
Employees
N/A
9
Industry
Biotechnology: Pharmaceutical Preparations
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
13.7M
11.1M
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
COCP
JTAI
Price
$1.00
$7.06
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$6.00
$80.00
AVG Volume (30 Days)
102.5K
198.6K
Earning Date
05-15-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
54.65
N/A
EPS
N/A
N/A
Revenue
$12,712,091.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$0.73
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.86
$0.04
52 Week High
$2.19
$10.41

Technical Indicators

Market Signals
Indicator
COCP
JTAI
Relative Strength Index (RSI) 44.28 48.42
Support Level $1.00 $6.03
Resistance Level $1.11 $7.79
Average True Range (ATR) 0.06 0.75
MACD 0.01 -0.21
Stochastic Oscillator 54.31 34.20

Price Performance

Historical Comparison
COCP
JTAI

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). The company has one reportable and operating segment dedicated to the research and development company's novel orally administered antiviral influenza candidate. The company has pipeline products for diseases like : Influenza, Norovirus, Coronavirus, Respiratory Viruses, and Hepatitis C.

About JTAI Jet.AI Inc.

Jet AI Inc is principally involved in the sale of fractional and whole interests in aircraft, the sale of jet cards, which enable holders to use certain of the company's and other's aircraft at agreed-upon rates, the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third-party carriers as well as via the company's leased and managed aircraft, direct chartering of its HondaJet Elite aircraft by Cirrus Aviation Services, aircraft brokerage and monthly management and hourly operation of customer aircraft. It also offers the SaaS software to aircraft owners and operators generally: Reroute AI; and DynoFlight. The company operates in a single operating and reportable segment which is private aviation services.

Share on Social Networks: